POSEIDA THERAPEUTICS INC

CUSIP: 73730P108 Class: Common Stock

Pentwater Capital Management LP's Holding History (CIK: 0001425851)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 8,625,000 Value ($000) $82,800 Avg Close — Range —
Q3 2024
Shares 5,975,000 Value ($000) $17,089 Avg Close — Range —
Q2 2024
Shares 5,975,000 Value ($000) $17,447 Avg Close — Range —
Q1 2024
Shares 5,975,000 Value ($000) $19,060 Avg Close — Range —
Q4 2023
Shares 5,975,000 Value ($000) $20,076 Avg Close — Range —
Q3 2023
Shares 5,975,000 Value ($000) $14,221 Avg Close — Range —
Q2 2023
Shares 5,975,000 Value ($000) $10,516 Avg Close — Range —
Q1 2023
Shares 5,975,000 Value ($000) $18,403 Avg Close — Range —
Q4 2022
Shares 5,975,000 Value ($000) $31,668 Avg Close — Range —
Q3 2022
Shares 5,975,000 Value ($000) $21,092 Avg Close — Range —
Q2 2022
Shares 4,967,227 Value ($000) $12,815 Avg Close — Range —
Q1 2022
Shares 4,967,227 Value ($000) $22,253 Avg Close — Range —
Q4 2021
Shares 4,967,227 Value ($000) $33,827 Avg Close — Range —
Q3 2021
Shares 4,967,227 Value ($000) $36,211 Avg Close — Range —
Q2 2021
Shares 4,967,227 Value ($000) $49,772 Avg Close — Range —
Q1 2021
Shares 4,967,227 Value ($000) $47,437 Avg Close — Range —
Q4 2020
Shares 4,967,227 Value ($000) $54,490 Avg Close — Range —
Q3 2020
Shares 4,879,490 Value ($000) $43,281 Avg Close — Range —